In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
The Sustainable Markets Initiative (SMI), a network of global CEOs and private sector corporations targeting planet-friendly growth, has created a new task force focused on the healthcare sector. 4 November 2021
Pharmaceutical
French drugmaker Ipsen has appointed Mari Scheiffele as executive vice president and president, Specialty Care International, effective November 1, 2021. 11 October 2021
Pharmaceutical
Swiss privately-held ophthalmics company Oculis has appointed Dr Joanne Chang as chief medical officer and head of portfolio management. 7 October 2021
Pharmaceutical
Aamir Malik has joined US pharma giant Pfizer as executive vice president and chief business innovation officer. 27 August 2021
Pharmaceutical
US healthcare giant Johnson & Johnson revealed yesterday that long-serving Alex Gorsky, who has held the posts of chairman and chief executive since 2012, will serve as executive chairman of the group. 20 August 2021
Pharmaceutical
US pharma major Eli Lilly has named Laura Steele president and general manager for UK, Ireland and Northern Europe. 11 August 2021
Pharmaceutical
Merck KGaA has named Hong Chow head of China and international for its Healthcare business sector. 23 July 2021
Pharmaceutical
GlaxoSmithKline has confirmed the current head of its consumer health joint venture (JV) will continue as chief executive once the unit is spun out into a standalone business. 23 July 2021
Pharmaceutical
Italian drugmaker Recordati’s board of directors has approved the appointment of Rob Koremans as chief executive effective December 1, 2021. 16 July 2021
Pharmaceutical
Frederik Paulsen is stepping down from his role as Ferring’s chairman of the board of directors after 33 years, the company has announced. 1 July 2021
Pharmaceutical
Market access strategist Jessamy Baird has been named the managing director of UK operations at French drugmaker Sanofi. 1 July 2021
Pharmaceutical
Spanish skincare specialist Almirall has appointed Dr Karl Ziegelbauer as chief scientific officer of the company, effective July 7. 11 June 2021
Pharmaceutical
Germany’s Merck KGaA is further pushing its science and technology based strategic growth trajectory with two appointments to key senior leadership positions on Group level. In both cases internal candidates will be promoted which underlines the high quality of Merck’s top talent pipeline. 1 June 2021
Pharmaceutical
Specialty UK pharma company Shield Therapeutics, with a focus on addressing iron deficiency with its lead product Feraccru/Accrufer (ferric maltol), today announced that Greg Madison has been appointed as chief executive, with effect from Tuesday, June 1, 2021. 28 May 2021
Pharmaceutical
German pharma and life sciences firm Merck KGaA today announced changes in its operating model for its Healthcare business sector. 18 May 2021
Pharmaceutical
Catherine Owen, senior vice president of major markets at Bristol Myers Squibb, provides an Expert View on why increasing female representation on corporate boards isn’t just a numbers game. Women bring diverse perspectives that are needed more than ever. 7 May 2021
Pharmaceutical
US biotech Cogent Biosciences has named John Robinson the company’s chief scientific officer (CSO). 7 April 2021
Pharmaceutical
GlaxoSmithKline, the majority shareholder of Galvani Bioelectronic, today announced the termination of Moncef Slaoui as chairman of the Galvani board of directors, effective immediately. 24 March 2021
Pharmaceutical
British clinical stage drug development company Evgen Pharma today announced that Helen Kuhlman will be joining the company as chief business officer, effective April 1, 2021. 22 March 2021
Pharmaceutical
US pharma giant Merck & Co yesterday revealed that Michael Nally, chief marketing officer, Human Health, will leave the company at the end of March, in order to take up a leadership opportunity with another company. 18 March 2021
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze